Patent BE524630A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5480980A Expired / Lapsed US ⏱️ 0.0 years remaining

7-Deaza-2'-deoxyguanosine nucleotides and nucleic acids analogs thereof

Assignee: Roche Diagnostics GmbH
•
Filing: 1988-11-14
•
Granted: 1996-01-02
•
Expires: 2008-11-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention provides 7-deaza-2'-deoxy-guanosine nucleotides of the general formula: <IMAGE> wherein R is a -PO3H2, -P2O6H3 or -P3O9H4 residue or an alkali metal, alkaline earth metal or ammonium salt of the phosphate groups. The present invention also provides processes for the preparation of these nucleotides and is also concerned with the use thereof in the sequencing of DNA.

Inventors

  • 👤 Frank Seela

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 14:49
CPC Classifications
C; C07; C07H; C07H19/00; C07H19/02; C07H19/04; C07H19/16; C07H19/20; C07H19/14

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 31 words
A compound of the formula ##STR4## wherein R is PO 3 H 2 , P 2 O 6 H 3 or an alkali metal, alkaline earth metal, or ammonium salt thereof.
Claim 2
Dependent Claim 31 words
A compound of the formula ##STR4## wherein R is PO 3 H 2 , P 2 O 6 H 3 or an alkali metal, alkaline earth metal, or ammonium salt thereof.
Claim 3
Dependent Claim 8 words
The compound of claim 1, designated 7-deaza-2'-deoxyguanosine 5'-diphosphate.
Claim 4
Dependent Claim 8 words
The compound of claim 1, designated 7-deaza-2'-deoxyguanosine 5'-monophosphate.
Claim 5
Dependent Claim 17 words
A desoxyribonucleic acid sequence comprising 7-deazaguanine as a nucleic base, wherein said base has the formula: ##STR5##
Claim 6
Dependent Claim 17 words
A desoxyribonucleic acid sequence comprising 7-deazaguanine as a nucleic base, wherein said base has the formula: ##STR5##
Claim 7
Dependent Claim 34 words
A nucleic acid sequence having a terminal nucleotide derived from a nucleotide of the formula: ##STR6## where R is PO 3 H 2 or an alkali metal, alkaline earth metal or ammonia salt thereof.
Claim 8
Dependent Claim 34 words
A nucleic acid sequence having a terminal nucleotide derived from a nucleotide of the formula: ##STR6## where R is PO 3 H 2 or an alkali metal, alkaline earth metal or ammonia salt thereof.
Claim 9
Dependent Claim 34 words
A nucleic acid sequence having incorporated therein at least one nucleotide of the formula ##STR7## wherein R is PO 3 H 2 , or an alkali metal, alkaline earth metal or ammonium salt thereof.
Claim 10
Dependent Claim 34 words
A nucleic acid sequence having incorporated therein at least one nucleotide of the formula ##STR7## wherein R is PO 3 H 2 , or an alkali metal, alkaline earth metal or ammonium salt thereof.
Claim 11
Dependent Claim 43 words
A nucleic acid sequence having a terminal nucleotide derived from a nucleotide of the formula: ##STR8## where R is P 2 O 6 H 3 or P 3 O 9 H 4 or an alkali metal, alkaline earth metal or ammonia salt thereof.
Claim 12
Dependent Claim 43 words
A nucleic acid sequence having a terminal nucleotide derived from a nucleotide of the formula: ##STR8## where R is P 2 O 6 H 3 or P 3 O 9 H 4 or an alkali metal, alkaline earth metal or ammonia salt thereof.
Claim 13
Dependent Claim 17 words
The nucleic acid sequence of claim 7 wherein R is P 3 O 9 H 4 .
Claim 14
Dependent Claim 17 words
The nucleic acid sequence of claim 7, wherein R is P 2 O 6 H 3 .

References Cited (Backward Citations)

US3337530A Cited
US4500707A Cited
US4804748A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1999-01-01 1999-07-03 2000-01-02 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2003-01-01 2003-07-03 2004-01-02 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2007-01-01 2007-07-03 2008-01-02 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag